Patrys is delighted to be participating in the V-Con Biotechs conference this week.
Presented by Stockhead, V-Con is an opportunity to hear the latest developments from Australia’s leading biotech companies.
Our CEO and MD, Dr James Campbell, has shared an update on Patrys’ activities and an explanation of why he sees such a bright future for the deoxymab platform, both with PAT-DX1 and with the broader platform applications.